Dermatology Series

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

Dermatology Series

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

Dermatology Series

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

Dermatology Series

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

Dermatology Series

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

COVID-19 Webinar

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

  • Free

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

COVID-19 Webinar

Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases and Beyond

  • Free

About this course

General

Skill level: All levels
Estimated time to complete activity: 1 Hour
Release date: April 07, 2020

Languages

English

Description

General immunosuppression can heighten the risk for infections, and this webinar will detail the risk for viral infections with immunosuppression and discuss strategies for immunosuppressive and immunomodulatory medication management during the COVID-19 pandemic.